Total Payments
$2,343
2024 Payments
$116.04
Companies
9
Transactions
34
Medicare Patients
14,813
Medicare Billing
$6.9M
Payment Breakdown by Category
Food & Beverage$982.42 (41.9%)
Travel$855.70 (36.5%)
Consulting$415.00 (17.7%)
Education$89.95 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $982.42 | 28 | 41.9% |
| Travel and Lodging | $855.70 | 4 | 36.5% |
| Consulting Fee | $415.00 | 1 | 17.7% |
| Education | $89.95 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biocompatibles, Inc. | $867.85 | 4 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $685.57 | 9 | $0 (2022) |
| Progenics Pharmaceuticals, Inc. | $223.09 | 4 | $0 (2023) |
| Spectrum Pharmaceuticals Inc. | $161.44 | 6 | $0 (2018) |
| GE HEALTHCARE | $140.99 | 5 | $0 (2017) |
| Astellas Pharma US Inc | $118.94 | 3 | $0 (2018) |
| Tempus AI, Inc | $89.08 | 1 | $0 (2024) |
| Blue Earth Diagnostics Limited | $29.15 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $26.96 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.04 | 2 | Tempus AI, Inc ($89.08) |
| 2023 | $158.12 | 3 | Progenics Pharmaceuticals, Inc. ($128.97) |
| 2022 | $509.12 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($415.00) |
| 2020 | $42.26 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($42.26) |
| 2019 | $485.81 | 2 | Biocompatibles, Inc. ($461.40) |
| 2018 | $737.89 | 13 | Biocompatibles, Inc. ($406.45) |
| 2017 | $293.83 | 9 | GE HEALTHCARE ($140.99) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $89.08 | General |
| 12/06/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $105.86 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/22/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/30/2023 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Diagnostic Imaging | ||||||
| 08/25/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Consulting Fee | Cash or cash equivalent | $415.00 | General |
| Category: Oncology | ||||||
| 05/12/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $70.05 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/14/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Oncology | ||||||
| 01/08/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Oncology | ||||||
| 03/13/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Oncology | ||||||
| 01/25/2019 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Travel and Lodging | Cash or cash equivalent | $461.40 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 12/13/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 11/01/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 10/31/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: Oncology | ||||||
| 10/26/2018 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Travel and Lodging | In-kind items and services | $280.30 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 10/26/2018 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Travel and Lodging | In-kind items and services | $75.00 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 10/26/2018 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Food and Beverage | In-kind items and services | $51.15 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 09/24/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $112.51 | General |
| Category: Oncology | ||||||
| 08/14/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Oncology | ||||||
| 06/18/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $96.26 | General |
| Category: Oncology | ||||||
| 06/18/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Oncology | ||||||
| 06/05/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Oncology | ||||||
| 05/09/2018 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: CARDIOLOGY | ||||||
| 03/22/2018 | Spectrum Pharmaceuticals Inc. | Zevalin (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 5,575 | 16,121 | $11.1M | $4.1M |
| 2022 | 36 | 3,586 | 4,517 | $3.2M | $852,521 |
| 2021 | 33 | 2,920 | 3,284 | $2.9M | $804,103 |
| 2020 | 29 | 2,732 | 3,456 | $3.4M | $1.2M |
Total Patients
14,813
Total Services
27,378
Medicare Billing
$6.9M
Procedure Codes
181
All Medicare Procedures & Services
181 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | Office | 2023 | 18 | 7,959 | $1.9M | $1.5M | 78.4% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 471 | 562 | $2.5M | $818,946 | 32.2% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 123 | 1,260 | $1.9M | $615,355 | 32.6% |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | Office | 2023 | 78 | 78 | $413,068 | $172,067 | 41.7% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 482 | 584 | $730,000 | $164,203 | 22.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 692 | 699 | $619,600 | $137,515 | 22.2% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 71 | 93 | $440,634 | $136,096 | 30.9% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Office | 2023 | 40 | 40 | $149,640 | $57,153 | 38.2% |
| A9592 | Copper cu-64, dotatate, diagnostic, 1 millicurie | Office | 2023 | 14 | 67 | $167,098 | $56,866 | 34.0% |
| 78814 | Nuclear medicine study limited area with ct scan | Office | 2023 | 31 | 31 | $124,527 | $44,838 | 36.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 261 | 1,044 | $127,092 | $41,651 | 32.8% |
| 78830 | Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | Office | 2023 | 100 | 102 | $158,201 | $40,882 | 25.8% |
| A9520 | Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries | Office | 2023 | 68 | 68 | $69,356 | $35,133 | 50.7% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Office | 2023 | 81 | 81 | $79,542 | $26,245 | 33.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 417 | 419 | $257,600 | $25,936 | 10.1% |
| 78072 | Nuclear medicine study of parathyroid with spect and ct scan | Office | 2023 | 55 | 55 | $83,765 | $20,228 | 24.1% |
| A9562 | Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | Office | 2023 | 23 | 24 | $84,792 | $16,602 | 19.6% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Office | 2023 | 50 | 54 | $45,306 | $13,480 | 29.8% |
| 78315 | Nuclear medicine study of bone taken at different times | Office | 2023 | 46 | 46 | $45,034 | $13,374 | 29.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 183 | 183 | $58,428 | $9,879 | 16.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 360 | 664 | $556,432 | $8,912 | 1.6% |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | Office | 2023 | 35 | 35 | $26,670 | $8,356 | 31.3% |
| 79101 | Radioactive drug therapy through a vein | Office | 2023 | 31 | 68 | $28,560 | $8,331 | 29.2% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Office | 2023 | 28 | 28 | $25,431 | $7,618 | 30.0% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 312 | 313 | $57,966 | $7,585 | 13.1% |
About Dr. William Pace, MD
Dr. William Pace, MD is a Nuclear Medicine healthcare provider based in Camarillo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326096785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Pace, MD has received a total of $2,343 in payments from pharmaceutical and medical device companies, with $116.04 received in 2024. These payments were reported across 34 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($982.42).
As a Medicare-enrolled provider, Pace has provided services to 14,813 Medicare beneficiaries, totaling 27,378 services with total Medicare billing of $6.9M. Data is available for 4 years (2020–2023), covering 181 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Medicine
- Location Camarillo, CA
- Active Since 05/05/2006
- Last Updated 06/18/2025
- Taxonomy Code 207U00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326096785
Products in Payments
- THERASPHERE - BIO (Device) $867.85
- Xofigo (Drug) $685.57
- PYLARIFY (Drug) $223.09
- Zevalin (Drug) $161.44
- Axumin (Drug) $29.15
- LUTATHERA (Drug) $26.96
- Lexiscan (Drug) $16.17
- LEXISCAN (Drug) $12.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.